Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ines Maria Vaz Duarte Luis"'
Autor:
Nicolas Roche, Jean-Bernard Le Provost, Maria-Alice Borinelli-Franzoi, Diane Boinon, Elise Martin, Gwenn Menvielle, Agnès Dumas, Sofia Rivera, Angelica Conversano, Margarida Matias, Alessandro Viansone, Antonio Di Meglio, Suzette Delaloge, Ines-Maria Vaz-Duarte-Luis, Barbara Pistilli, Léonor Fasse
Publikováno v:
European Journal of Oncology Nursing. 62:102259
Autor:
Aurélie Capel, Christelle Levy, Idlir Licaj, Marie Lange, Florence Joly, Laurence Vanlemmens, Paul Cottu, Johan Le Fel, Anne-Laure Martin, Ines Maria Vaz Duarte Luis, Florence Lerebours, Charles Coutant, Sarah Dauchy, Jean Petrucci, Cécile Charles, Olivier Rigal, Isabelle Hardy-Léger, Fabrice Andre, Pauline Roux, Sibille Everhard
Publikováno v:
Psycho-Oncology. 30:463-470
Objective Cognitive complaints are more frequent in women with breast cancer (BC) than in healthy controls and can be present before any treatment. Findings regarding contributive factors remain inconsistent. This study aimed to identify different gr
Autor:
Maria Alice B Franzoi, Lena Degousee, Elise Martin, Marion Aupomerol, Davide Soldato, Antonio Di Meglio, Aude Barbier, Celine Lazorthes, Hajer Chaouachi, Nathalie Renvoise, Diane Boinon, Leonor Fasse, Jean Bernard Le-Provost, Johanna Arvis, Anne De-Jesus, Bruno Raynard, Suzette Delaloge, Barbara Pistilli, Florian Scotte, Ines Maria Vaz Duarte Luis
Publikováno v:
Journal of Clinical Oncology. 40:221-221
221 Background: Optimal comprehensive survivorship care, beyond screening of recurrences and new cancers, and including health promotion, management of physical as well as psychosocial needs and chronic conditions is insufficiently delivered. To incr
Autor:
Cécile Charles, Céline Bourgier, Linda Cambon, Sarah Dauchy, Séverine Chiesa, François Alla, Andréa Cavalcanti, Jean-Claude Ferrandez, Estelle Favré, Laure Gueroult-Accolas, Christine Mateus, Ines Maria Vaz Duarte Luis, Lucille Karsenti, Damien Vansteene, Ilaria Montagni, Claude Boiron
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, A paraître, ⟨10.1016/j.bulcan.2021.02.006⟩
Bulletin du Cancer, John Libbey Eurotext, A paraître, ⟨10.1016/j.bulcan.2021.02.006⟩
INTRODUCTION: Fatigue is a frequent and disturbing symptom in oncology but remains undertreated. Given the absence of effective drug treatment, non-pharmacological interventions have a prominent place in the treatment of fatigue. However, they are re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abbba30af410ce056a488965788c610
http://hdl.handle.net/20.500.12278/79275
http://hdl.handle.net/20.500.12278/79275
Autor:
Johanna Arvis, Barbara Pistilli, Arnauld S. Gbenou, Arlindo R. Ferreira, Ines Maria Vaz Duarte Luis, Antonio Di Meglio, Cécile Charles, Benoit Fagnou, Marine Blond, Elise Martin, Mahasti Saghatchian
Publikováno v:
JMIR Cancer, Vol 7, Iss 1, p e23927 (2021)
JMIR Cancer
JMIR Cancer
Background Physical activity has shown beneficial effects in the treatment of breast cancer fatigue; nevertheless, a significant portion of patients remain insufficiently physically active after breast cancer. Currently most patients have a smartphon
Autor:
Charles Coutant, Agnès Dumas, Laurence Vanlemmens, Suzette Delaloge, Christelle Mesleard, Olivier Tredan, Gwenn Menvielle, Sandrine Pinto, Paul Cottu, Mayssam El Mouhebb, Jérôme Lemonnier, Cécile Charles, Thomas Bovagnet, A. Lesur, Sarah Dauchy, Fabrice Andre, Antonio Di Meglio, Patrick Arveux, Christelle Levy, Ines Maria Vaz Duarte Luis, Florence Lerebours
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (7), pp.734-743. ⟨10.1200/jco.19.01726⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (7), pp.734-743. ⟨10.1200/jco.19.01726⟩
PURPOSE Adverse effects of breast cancer treatment can negatively affect survivors’ work ability. Previous reports lacked detailed clinical data or health-related patient-reported outcomes (PROs) and did not prospectively assess the combined impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8e9248494ef063680decfa22c4ba9d
https://hal.archives-ouvertes.fr/hal-03088680
https://hal.archives-ouvertes.fr/hal-03088680
Autor:
Ann H. Partridge, Antonio Di Meglio, Sibille Everhard, Gwenn Menvielle, Cécile Charles, Christelle Levy, Patricia A. Ganz, Anne-Laure Martin, Carole Tarpin, Laurence Vanlemmens, J. Havas, Agnès Dumas, Suzette Delaloge, Elise Martin, Olivier Rigal, Fabrice Andre, Barbara Pistilli, Ines Maria Vaz Duarte Luis, Charles Coutant, Stefan Michiels
Publikováno v:
Journal of Clinical Oncology. 39:12022-12022
12022 Background: CRF is among the most common and troublesome symptoms experienced by BCS. While preventing severe post-tx CRF is a major survivorship need, limited tools exist to predict this risk. We aimed to describe the long-term prevalence rate
Autor:
Thomas Bovagnet, Gwenn Menvielle, G. Ruiz-de-Azua Unzurrunzaga, Barbara Pistilli, Antoine Arnaud, Charles Coutant, Olivier Arsene, Paul-Henri Cottu, Agnès Dumas, E. Caumette, J. Havas, Sibille Everhard, A. Di Meglio, Ed. Martin, Philippe Rouanet, Mahmoud Ibrahim, Johanna Wassermann, Roman Rouzier, Ines Maria Vaz Duarte Luis, A-L. Martin
Publikováno v:
Annals of Oncology. 31:S334-S335
Autor:
Lee W. Jones, Ann H. Partridge, Johanna Wassermann, Arnauld S. Gbenou, Stefan Michiels, Agnès Dumas, Fabrice Andre, Mahmoud Ibrahim, Ines Maria Vaz Duarte Luis, Lucia Del Mastro, Thomas Bovagnet, Jérôme Lemonnier, Anne Laure Martin, Laurence Vanlemmens, Antonio Di Meglio, Olivier Arsene, Elise Martin, Sandrine Pinto, Gwenn Menvielle, Jennifer A. Ligibel, Arlindo R. Ferreira
Publikováno v:
European Society for Medical Oncology
European Society for Medical Oncology, 2020, 5 (6), pp.e000908. ⟨10.1136/esmoopen-2020-000908⟩
European Society for Medical Oncology, BMJ Journals, 2020, 5 (6), pp.e000908. ⟨10.1136/esmoopen-2020-000908⟩
ESMO Open, Vol 5, Iss 6 (2020)
ESMO Open
European Society for Medical Oncology, 2020, 5 (6), pp.e000908. ⟨10.1136/esmoopen-2020-000908⟩
European Society for Medical Oncology, BMJ Journals, 2020, 5 (6), pp.e000908. ⟨10.1136/esmoopen-2020-000908⟩
ESMO Open, Vol 5, Iss 6 (2020)
ESMO Open
International audience; BackgroundMany breast cancer (BC) survivors are employed at diagnosis and are expected to return to work after treatment. Among them, around 50% are overweight or obese. There are limited data about the impact of body weight o
Autor:
Stephen B. Edge, Michael J. Hassett, Melissa E. Hughes, Beverly Moy, Ines Maria Vaz Duarte Luis, H Rugo, Richard L. Theriault, Eric P. Winer, Angel M. Cronin, Nan Lin
Publikováno v:
Cancer Research. 75:P2-13
Background: More than two decades ago several trials have shown equivalent survival between breast conserving surgery (BCS) and MAST. Among a contemporary cohort of patients (pts) with Stage I BC who would be expected to be candidates for BCS; we exa